97 related articles for article (PubMed ID: 20507057)
1. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.
Tessem MB; Selnaes KM; Sjursen W; Tranø G; Giskeødegård GF; Bathen TF; Gribbestad IS; Hofsli E
J Proteome Res; 2010 Jul; 9(7):3664-70. PubMed ID: 20507057
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability in microsatellite-unstable and stable colon cancer.
Trautmann K; Terdiman JP; French AJ; Roydasgupta R; Sein N; Kakar S; Fridlyand J; Snijders AM; Albertson DG; Thibodeau SN; Waldman FM
Clin Cancer Res; 2006 Nov; 12(21):6379-85. PubMed ID: 17085649
[TBL] [Abstract][Full Text] [Related]
4. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
6. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses.
Righi V; Durante C; Cocchi M; Calabrese C; Di Febo G; Lecce F; Pisi A; Tugnoli V; Mucci A; Schenetti L
J Proteome Res; 2009 Apr; 8(4):1859-69. PubMed ID: 19714812
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
Kim GP; Colangelo LH; Wieand HS; Paik S; Kirsch IR; Wolmark N; Allegra CJ;
J Clin Oncol; 2007 Mar; 25(7):767-72. PubMed ID: 17228023
[TBL] [Abstract][Full Text] [Related]
10. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
11. Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer.
Thiéfin G; Dupont A; Guillou PJ; Vitry F; Bouche O; Yaziji N; Lagarde S; Maquart FX; Palot JP; Hornebeck W; Diebold MD
Anticancer Res; 2007; 27(1B):583-8. PubMed ID: 17348445
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.
des Guetz G; Mariani P; Cucherousset J; Benamoun M; Lagorce C; Sastre X; Le Toumelin P; Uzzan B; Perret GY; Morere JF; Breau JL; Fagard R; Schischmanoff PO
Anticancer Res; 2007; 27(4C):2715-9. PubMed ID: 17695437
[TBL] [Abstract][Full Text] [Related]
13. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
[TBL] [Abstract][Full Text] [Related]
15. [Detection of microsatellite instability in colorectal cancer by fluorescence multiplex polymerase chain reaction and its clinical value].
Jin HY; Lai RS; Ding YJ; Xie L; Yang BL; Liu F; Ding SQ; Ge YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):217-20. PubMed ID: 17520377
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients.
Yakoub D; Keun HC; Goldin R; Hanna GB
Cancer Res; 2010 Nov; 70(22):9129-36. PubMed ID: 20884633
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
18. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL
J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.
Tahara T; Inoue N; Hisamatsu T; Kashiwagi K; Takaishi H; Kanai T; Watanabe M; Ishii H; Hibi T
J Gastroenterol Hepatol; 2005 May; 20(5):710-5. PubMed ID: 15853983
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
